Cargando…

A cohort study of mortality predictors in patients with acute exacerbation of chronic fibrosing interstitial pneumonia

OBJECTIVES: To assess clinical, laboratory and radiographic findings associated with outcomes and to clarify more practical ways to predict hospital mortality in patients with acute exacerbation (AE) of chronic fibrosing interstitial pneumonia (CFIP). DESIGN: Single-centre retrospective cohort study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Usui, Yutaka, Kaga, Akiko, Sakai, Fumikazu, Shiono, Ayako, Komiyama, Ken-ichiro, Hagiwara, Koichi, Kanazawa, Minoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2013
Materias:	Respiratory Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731726/ https://www.ncbi.nlm.nih.gov/pubmed/23903809 http://dx.doi.org/10.1136/bmjopen-2013-002971

Ejemplares similares

Imaging Diagnosis of Interstitial Pneumonia with Emphysema (Combined Pulmonary Fibrosis and Emphysema)
por: Sakai, Fumikazu, et al.
Publicado: (2012)

Monocyte count and the risk for acute exacerbation of fibrosing interstitial lung disease: A retrospective cohort study
por: Kawamura, Kodai, et al.
Publicado: (2020)

Acute exacerbations of progressive-fibrosing interstitial lung diseases
por: Kolb, Martin, et al.
Publicado: (2018)

Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study
por: Hozumi, Hironao, et al.
Publicado: (2013)

Emphysema and Interstitial Pneumonia in Rheumatoid Arthritis
por: Sakai, Fumikazu
Publicado: (2018)

Biomarkers of Fibroproliferative Healing in Fibrosing Idiopathic Interstitial Pneumonias
por: Vasakova, Martina, et al.
Publicado: (2012)

Systematic review and meta-analysis of the prognosis and prognostic factors of interstitial pneumonia with autoimmune features
por: Kamiya, Hiroyuki, et al.
Publicado: (2019)

Nocturnal emergency department visits, duration of symptoms and risk of hospitalisation among adults with asthma exacerbations: a multicentre observational study
por: Yasuda, Hideto, et al.
Publicado: (2016)

Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias
por: Hoeper, Marius M., et al.
Publicado: (2015)

Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases
por: Salonen, Johanna, et al.
Publicado: (2020)

Impact of lymphocyte differential count > 15% in BALF on the mortality of patients with acute exacerbation of chronic fibrosing idiopathic interstitial pneumonia
por: Takei, Reoto, et al.
Publicado: (2017)

Association of serum monomeric periostin level with outcomes of acute exacerbation of idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia
por: Shimizu, Hiroshige, et al.
Publicado: (2021)

Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan
por: Minegishi, Yuji, et al.
Publicado: (2020)

Serum autotaxin levels in chronic disease and acute exacerbation of fibrosing interstitial lung disease
por: Isshiki, Takuma, et al.
Publicado: (2022)

The utility of the Japanese Association for Acute Medicine DIC scoring system for predicting survival in acute exacerbation of fibrosing idiopathic interstitial pneumonia
por: Yamazaki, Ryo, et al.
Publicado: (2019)

Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias
por: Traila, Daniel, et al.
Publicado: (2017)

COVID-19 Pneumonia Resembling an Acute Exacerbation of Interstitial Pneumonia
por: Kitayama, Takaaki, et al.
Publicado: (2020)

The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study
por: Schmidt, Sigrun Alba Johannesdottir, et al.
Publicado: (2014)

Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience
por: Kawamura, Kodai, et al.
Publicado: (2019)

Predictors of Mortality in Progressive Fibrosing Interstitial Lung Diseases
por: Chen, Xianqiu, et al.
Publicado: (2021)

Progression of fibrosing interstitial lung disease
por: Wong, Alyson W., et al.
Publicado: (2020)

Management of Fibrosing Interstitial Lung Diseases
por: Maher, Toby M., et al.
Publicado: (2019)

Diagnostic accuracy of urinary antigen tests for pneumococcal pneumonia among patients with acute respiratory failure suspected pneumonia: a systematic review and meta-analysis
por: Yasuo, Shunsuke, et al.
Publicado: (2022)

Microbial communities in the respiratory tract of patients with interstitial lung disease
por: Garzoni, Christian, et al.
Publicado: (2013)

Combination of computed tomography imaging pattern and severity of respiratory failure as factors associated with prognosis for acute exacerbation of idiopathic chronic fibrosing interstitial pneumonia
por: Enokida, Keito, et al.
Publicado: (2023)

Effect of nintedanib on acute exacerbations of fibrosing interstitial lung diseases: a national database study in Japan
por: Urushiyama, Hirokazu, et al.
Publicado: (2022)

Protocol for an observational study to identify potential predictors of an acute exacerbation in patients with chronic obstructive pulmonary disease (the PACE Study)
por: Kenn, Klaus, et al.
Publicado: (2021)

Relationship between heart failure and the risk of acute exacerbation of COPD
por: Axson, Eleanor L, et al.
Publicado: (2021)

Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases
por: Brown, Kevin K., et al.
Publicado: (2022)

The Burden of Progressive-Fibrosing Interstitial Lung Diseases
por: Cottin, Vincent, et al.
Publicado: (2022)

Management of patients with fibrosing interstitial lung diseases
por: Morrow, Lee E, et al.
Publicado: (2021)

Fibrosing interstitial lung diseases: knowns and unknowns
por: Cottin, Vincent, et al.
Publicado: (2019)

DECAF score as a mortality predictor for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Huang, Qiangru, et al.
Publicado: (2020)

Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations
por: O'Reilly, Philip J, et al.
Publicado: (2013)

Predictors of 30-day readmission following hospitalisation with community-acquired pneumonia
por: Chakrabarti, Biswajit, et al.
Publicado: (2021)

Association of serum high-mobility group box protein 1 level with outcomes of acute exacerbation of idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia
por: Shimizu, Hiroshige, et al.
Publicado: (2018)

Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis
por: Nakashita, Tamao, et al.
Publicado: (2014)

Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study
por: Cao, Mengshu, et al.
Publicado: (2019)

Specialist pneumonia intervention nurse service improves pneumonia care and outcome
por: Free, Robert C, et al.
Publicado: (2021)

Systematic review and meta-analysis of prognostic factors of acute exacerbation of idiopathic pulmonary fibrosis
por: Kamiya, Hiroyuki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8tbetas88pe2a9igjsielk1og7